Skip to content

Implantable Loop Recorders in Haemodialysis Patients

Cardio-Renal Arrhythmia Study in Haemodialysis patients using Implantable Loop Recorders (CRASH-ILR)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN35846572
Enrollment
30
Registered
2017-06-28
Start date
2011-08-30
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Cardiovascular disease, Primary sub-specialty: Arrhythmia Circulatory System Arrhythmia

Interventions

Participants are recruited from a single tertiary nephrology centre in the UK and all were receiving haemodialysis three times a week. Participants receive the intervention of the hav

Sponsors

Queen Alexandra Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. End Stage Renal Failure (ESRF) 2. Received regular haemodialysis for a minimum of 90 days prior to study entry and is expected to continue with haemodialysis indefinitely or until renal transplant 3. At least 18 years of age 4. Willing and able to comply with investigational plan and willing to remain available for follow-up through to study closure 5. Willing and able to sign/date the study informed consent

Exclusion criteria

Exclusion criteria: 1. Myocardial infarction in preceding 40 days prior to enrolment 2. Already implanted with a cardiac device, such as pacemaker, defibrillator or implantable loop recorder (ILR) 3. Life expectancy less than one year in the opinion of an Investigator 4. Enrolled in another research study 5. Expected to have poor compliance with the study protocol 6. Pregnancy or breastfeeding 7. Haemodialysis via leftsided tunnelled central venous catheter 8. Expected to require a thoracic magnetic resonance image (MRI)

Design outcomes

Primary

MeasureTime frame
1. Sudden cardiac death (SCD) is measured using continuous ECG data downloaded from the ILR device. In addition to clinical information and post mortem examination where performed. 2. Implantation of pacing device is measured by reporting the number of pacemakers or defibrillators that were implanted during the course of the study.

Secondary

MeasureTime frame
Development of significant arrhythmia necessitating medical intervention is measured using continuous ECG data from the ILR device.

Countries

England, United Kingdom

Contacts

Public ContactBibi Greenwood

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026